Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS/MS

Epigenetics and pathogenesis of systemic sclerosis; the ins and outs

(2018) Saeed Aslani et al.   HUMAN IMMUNOLOGY

Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of IFN-Associated Genes in CD4 + and CD8 + T Cells

(2018) Weifeng Ding et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

New insights into the genetics and epigenetics of systemic sclerosis

(2018) Chiara Angiolilli et al.   Nature Reviews Rheumatology

Epigenetic factors as drivers of fibrosis in systemic sclerosis

(2017) Christina Bergmann et al.   Epigenomics

Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2′-deoxycytidine level in cultured cancerous cell lines

(2017) Marek Foksinski et al.   PLoS One

Enigmatic 5-hydroxymethyluracil: Oxidatively modified base, epigenetic mark or both?

(2016) Ryszard Olinski et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts

(2015) Mai Hattori et al.   EXPERIMENTAL DERMATOLOGY

Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis

(2015) T. Hua-Huy et al.   PATHOLOGIE BIOLOGIE

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?

(2011) Astrid Jüngel et al.   Expert Review of Clinical Immunology

Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis

(2009) W Lei et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY